• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两名慢性肾衰竭患者在使用西沙必利和克拉霉素治疗时发生尖端扭转型室速。

Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin.

作者信息

Sekkarie M A

机构信息

Department of Internal Medicine, Bluefield Regional Medical Center and West Virginia University, USA.

出版信息

Am J Kidney Dis. 1997 Sep;30(3):437-9. doi: 10.1016/s0272-6386(97)90291-2.

DOI:10.1016/s0272-6386(97)90291-2
PMID:9292575
Abstract

Patients with chronic renal failure are often on multiple medications and are at risk for the development of adverse effects from drug interactions. Two cases of torsades de pointes that followed the initiation of clarithromycin therapy in patients receiving long-term cisapride therapy are being reported. Elevated cisapride levels while on this combination with return to therapeutic range while on cisapride only was documented in one of the patients. The role of the inhibition of cytochrome P-4503A4 in the occurrence of the arrhythmia is discussed.

摘要

慢性肾衰竭患者通常服用多种药物,存在因药物相互作用而产生不良反应的风险。本文报告了2例在长期接受西沙必利治疗的患者中,加用克拉霉素治疗后发生尖端扭转型室速的病例。其中1例患者记录到,联合用药时西沙必利水平升高,而仅使用西沙必利时则恢复到治疗范围。本文还讨论了细胞色素P - 4503A4抑制在心律失常发生中的作用。

相似文献

1
Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin.两名慢性肾衰竭患者在使用西沙必利和克拉霉素治疗时发生尖端扭转型室速。
Am J Kidney Dis. 1997 Sep;30(3):437-9. doi: 10.1016/s0272-6386(97)90291-2.
2
Torsade de pointes induced by cisapride/clarithromycin interaction.西沙必利/克拉霉素相互作用诱发的尖端扭转型室速。
Ann Pharmacother. 1999 Jan;33(1):22-6. doi: 10.1345/aph.18107.
3
Cisapride-induced torsades de pointes.
J Cardiovasc Electrophysiol. 1998 Oct;9(10):1109-13. doi: 10.1111/j.1540-8167.1998.tb00888.x.
4
Cisapride and fatal arrhythmia.西沙必利与致命性心律失常
N Engl J Med. 1996 Jul 25;335(4):290-1. doi: 10.1056/NEJM199607253350416.
5
Torsades de pointes due to drug interaction between disopyramide and clarithromycin.丙吡胺与克拉霉素药物相互作用导致尖端扭转型室速。
Heart Dis. 1999 Sep-Oct;1(4):206-7.
6
Clarithromycin-Induced Torsades de Pointes.
Am J Ther. 2016 May-Jun;23(3):e955-6. doi: 10.1097/MJT.0000000000000109.
7
[Clarithromycin-induced torsades de pointes].
Nihon Naika Gakkai Zasshi. 2003 Jan 10;92(1):143-5. doi: 10.2169/naika.92.143.
8
Clarithromycin induced torsade de pointes.克拉霉素诱发尖端扭转型室性心动过速。
Ir J Med Sci. 2008 Mar;177(1):67-8. doi: 10.1007/s11845-007-0057-3. Epub 2007 Jul 7.
9
Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.与西沙必利相关的QT间期延长和室性心律失常的上市后报告以及美国食品药品监督管理局的监管行动。
Am J Gastroenterol. 2001 Jun;96(6):1698-703. doi: 10.1111/j.1572-0241.2001.03927.x.
10
QT prolongation and Torsades de Pointes associated with clarithromycin.
Am J Med. 1998 Apr;104(4):395-6. doi: 10.1016/s0002-9343(98)00059-x.

引用本文的文献

1
Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.老年患者药物性尖端扭转型室速中QT间期延长剂的鲁莽使用。
Z Gerontol Geriatr. 2018 Jan;51(1):41-47. doi: 10.1007/s00391-016-1155-5. Epub 2016 Nov 22.
2
Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients.慢性肾脏病及透析患者中大环内酯类抗生素毒性的临床表现
Clin Kidney J. 2014 Dec;7(6):507-12. doi: 10.1093/ckj/sfu098. Epub 2014 Sep 18.
3
Risk factors for drug-induced long-QT syndrome.药物性长QT综合征的危险因素。
Neth Heart J. 2005 Feb;13(2):47-56.
4
Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.克拉霉素、QTc间期延长与尖端扭转型室速:对病例报告进行研究的必要性
Ther Adv Infect Dis. 2013 Aug;1(4):121-38. doi: 10.1177/2049936113497203.
5
Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.应用布拉德福德·希尔标准评估西沙必利所致心律失常的因果关系:药物警戒中评估因果关联的一个模型
Drug Saf. 2007;30(4):333-46. doi: 10.2165/00002018-200730040-00006.
6
QT prolongation with antimicrobial agents: understanding the significance.抗菌药物导致的QT间期延长:理解其意义
Drugs. 2004;64(10):1091-124. doi: 10.2165/00003495-200464100-00005.
7
Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.抗精神病药物心血管不良反应中的药代动力学因素。
Clin Pharmacokinet. 2004;43(1):33-56. doi: 10.2165/00003088-200443010-00003.
8
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.重症监护病房感染治疗的药代动力学方面:聚焦于药物相互作用。
Clin Pharmacokinet. 2001;40(11):833-68. doi: 10.2165/00003088-200140110-00004.
9
Evidence of impaired cisapride metabolism in neonates.新生儿西沙必利代谢受损的证据。
Br J Clin Pharmacol. 2001 Oct;52(4):419-25. doi: 10.1046/j.0306-5251.2001.01470.x.
10
Drug interactions with cisapride: clinical implications.西沙必利的药物相互作用:临床意义。
Clin Pharmacokinet. 2000 Jul;39(1):49-75. doi: 10.2165/00003088-200039010-00004.